|
RXRX Recursion Pharmaceuticals Inc 1601830 |
| Balance Sheet |
|
Current Assets
|
$603,462,000.00 |
|
Assets
|
$1,212,668,000.00 |
|
Current Liabilities
|
$119,886,000.00 |
|
Liabilities
|
$297,665,000.00 |
|
Equity
|
$915,003,000.00 |
|
Shares Out
|
534120235.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-187,048,000.00 |
|
Investing Cash Flow
|
$-2,297,000.00 |
| Market Analysis |
Market Cap
|
$1,783,961,584.90 |
|
Price
|
$3.34 |
|
BVPS
|
1.71 |
|
PB
|
1.95 |
|
EPS
|
-0.25 |
|
PS
|
58.15 |
|
FCF
|
$-187,350,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:32 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:22 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-25 |
-0.21 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-06 |
-0.22 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-0.41 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.36 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RXRX documents filed with the SEC.
RXRX Filings
Clear
